Rhone Ma Holdings Bhd Asset Resilience Ratio
Rhone Ma Holdings Bhd asset resilience ratio. Rhone Ma Holdings Bhd (5278) has an Asset Resilience Ratio of 0.11% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 5278 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Rhone Ma Holdings Bhd (2020–2025)
Asset resilience ratio of Rhone Ma Holdings Bhd from 2020 to 2025. This chart shows how Rhone Ma Holdings Bhd's Asset Resilience Ratio has changed over time. Read 5278 total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Rhone Ma Holdings Bhd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Rhone Ma Holdings Bhd total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | RM0.00 | 0% |
| Short-term Investments | RM292.65K | 0.11% |
| Total Liquid Assets | RM292.65K | 0.11% |
Asset Resilience Insights
- Limited Liquidity: Rhone Ma Holdings Bhd maintains only 0.11% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Rhone Ma Holdings Bhd Industry Peers by Asset Resilience Ratio
Compare Rhone Ma Holdings Bhd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Galderma Group N
SW:GALD |
Drug Manufacturers - Specialty & Generic | 3.56% |
|
Enzymatica publ AB
ST:ENZY |
Drug Manufacturers - Specialty & Generic | 22.17% |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 9.04% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Walvax BioTech
SHE:300142 |
Drug Manufacturers - Specialty & Generic | 2.20% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
Rhone Ma Holdings Bhd Asset Resilience Ratio by Year (2020–2025)
Rhone Ma Holdings Bhd asset resilience ratio by year from 2020 to 2025. The table below shows the annual Asset Resilience Ratio data for Rhone Ma Holdings Bhd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.11% | RM292.65K ≈ $73.48K |
RM258.49 Million ≈ $64.90 Million |
-0.01pp |
| 2024-12-31 | 0.13% | RM282.85K ≈ $71.01K |
RM225.45 Million ≈ $56.60 Million |
+0.01pp |
| 2023-12-31 | 0.12% | RM273.04K ≈ $68.55K |
RM230.59 Million ≈ $57.89 Million |
-1.05pp |
| 2022-12-31 | 1.17% | RM2.56 Million ≈ $643.31K |
RM219.43 Million ≈ $55.09 Million |
-1.17pp |
| 2021-12-31 | 2.34% | RM4.58 Million ≈ $1.15 Million |
RM195.81 Million ≈ $49.16 Million |
-0.08pp |
| 2020-12-31 | 2.42% | RM4.51 Million ≈ $1.13 Million |
RM185.99 Million ≈ $46.70 Million |
-- |
About Rhone Ma Holdings Bhd
Rhone Ma Holdings Berhad, an investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia. The company operates through Animal Health Products and Food Equipment; Food Ingredients; and others segments. It offers diagnostic laboratory analysis and consultation services to veterinary, agriculture, and … Read more